PDCD1 and neoplasm: Immune checkpoint molecules, particularly programmed death receptor 1 (PD-1) and programmed cell death-ligand 1 (PD-L1), have been proven to be more frequently present in tumor cells and tumor-infiltrating immune cells to disturb antitumor immune response [9].